Rezolute Announces Positive Data from its Phase 2b (RIZE) Study of RZ358 in Patients with Congenital Hyperinsulinism






Resolute Announces Positive Data From Its Phase 2B (RIZE) Study Of RZ358 In Patients With Congenital Hyperinsulinism – TechiLive.in















adplus-ads





Source link

Leave a Comment